Known targets — ChEMBL curated mechanism
GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL219243 | 1.00 | — | — | |
| SCHEMBL9937825 | 1.00 | — | — | |
| SCHEMBL1662398 | 1.00 | — | — | |
| SCHEMBL516205 | 1.00 | — | — | |
| Water SCHEMBL7511286 | 0.82 | — | — | |
| SCHEMBL410043 | 0.82 | — | — | |
| Phosphine SCHEMBL1149401 | 0.82 | — | — | |
| Water SCHEMBL7511283 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL9740278 | 0.82 | — | — | |
| SCHEMBL410044 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100068273-A1 | PHARMACEUTICAL FORMULATION, ITS USE, AND METHOD FOR ITS MANUFACTURE | BIONORICA AG (DE) | 2010-03-18 | — | — | US | claimed |
| US-7629005-B2 | Pharmaceutical formulation consisting of a plant dry extract with a calcium coating | BIONORICA AG (DE) | 2009-12-08 | — | — | US | claimed |
| EP-1392337-B2 | PHARMACEUTICAL FORMULATION CONSISTING OF A PLANT DRY EXTRACT WITH A CALCIUM COATING | BIONORICA AG (DE) | 2009-07-22 | — | — | EP | claimed |
| EP-1392337-B1 | PHARMACEUTICAL FORMULATION CONSISTING OF A PLANT DRY EXTRACT WITH A CALCIUM COATING | BIONORICA AG (DE) | 2005-11-30 | — | — | EP | claimed |
| US-20040151781-A1 | Pharmaceutical formulation consisting of a plant dry extract with a calcium coating | BIONORICA AG (DE) | 2004-08-05 | — | — | US | claimed |
| EP-4238556-A1 | GASTRORETENTIVE PHARMACEUTICAL DOSAGE FORM | Triastek, Inc. (CN) | 2023-09-06 | — | — | EP | disclosed |
| US-20100068273-A1 | PHARMACEUTICAL FORMULATION, ITS USE, AND METHOD FOR ITS MANUFACTURE | BIONORICA AG (DE) | 2010-03-18 | — | — | US | disclosed |
| US-7629005-B2 | Pharmaceutical formulation consisting of a plant dry extract with a calcium coating | BIONORICA AG (DE) | 2009-12-08 | — | — | US | disclosed |
| US-20040151781-A1 | Pharmaceutical formulation consisting of a plant dry extract with a calcium coating | BIONORICA AG (DE) | 2004-08-05 | — | — | US | disclosed |